Pregled bibliografske jedinice broj: 197564
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment // European journal of pharmacology, 517 (2005), 1-2; 132-143 doi:10.1016/j.ejphar.2005.05.023 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 197564 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment
Autori
Parnham, Michael ; Čulić, Ognjen ; Eraković, Vesna ; Munić, Vesna ; Popović-Grle, Sanja ; Barišić, Karmela ; Bosnar, Martina ; Brajša, Karmen ; Čepelak, Ivana ; Čužić, Snježana ; Glojnarić, Ines ; Manojlović, Zoran ; Novak-Mirčetić, Renata ; Orešković, Katarina ; Pavić-Beljak, Verica ; Radošević, Senka ; Sučić, Mirna
Izvornik
European journal of pharmacology (0014-2999) 517
(2005), 1-2;
132-143
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
azithromycin ; neutrophil ; chronic obstructive pulmonary disease (COPD) ; inflammatory marker ; cytokine
Sažetak
The anti-inflammatory potential of azithromycin in chronic obstructive pulmonary disease (COPD) patients was explored following a 17 standard oral dosing regimen. Patients with moderate and severe COPD were treated with azithromycin (500 mg, n =16) or placebo (n =8) 18 once daily for 3 days in a randomized, double blind design, to compare effects on inflammation markers with those seen in a previous study 19 in healthy volunteers. A battery of tests was made on serum, blood neutrophils and sputum on days 1 (baseline), 3, 4, 11, 18 and 32. In 20 comparison to placebo, azithromycin resulted in an early transient increase in serum nitrites plus nitrates (day 3), associated with a tendency 21 towards an increase in the blood neutrophil oxidative burst to phorbol myristic acetate. Subsequently, prolonged decreases in blood leukocyte and platelet counts, serum acute phase protein (including C reactive protein) and soluble E-selectin and blood neutrophil lactoferrin concentrations and a transient decrease in serum interleukin-8 were observed. Blood neutrophil glutathione peroxidase activity showed a prolonged increase after azithromycin treatment. The biphasic facilitatory-then-inhibitory response to azithromycin seen in healthy volunteers is not so clearly detectable in COPD patients, only potential anti-inflammatory effects. Treatment for longer periods may give therapeutic anti-inflammatory benefit in these patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
0006634
0006631
0098109
129-0000000-3385 - Citološki pokazatelji proliferacije stanica (Sučić, Mirna, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Pliva-Istraživački institut,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
Klinički bolnički centar Zagreb
Profili:
Vesna Eraković Haber
(autor)
Katarina Orešković
(autor)
Mirna Sučić
(autor)
Verica Pavičić-Beljak
(autor)
Renata Novak-Mirčetić
(autor)
Vesna Munić
(autor)
Ognjen Čulić
(autor)
Martina Bosnar
(autor)
Vesna Munić Kos
(autor)
Karmela Barišić
(autor)
Sanja Popović-Grle
(autor)
Snježana Čužić
(autor)
Zoran Manojlović
(autor)
Senka Radošević
(autor)
Ivana Čepelak
(autor)
Karmen Brajša
(autor)
Ines Glojnarić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE
- Chemical Abstracts
- BIOSIS
- EMBASE